CAPLYTA 21 mg/1
lumateperone · CAPSULE · Intra-Cellular Therapies, Inc
No Recall History
Plain English
CAPLYTA is a capsule containing lumateperone at 21 mg/1, taken oral. Manufactured by Intra-Cellular Therapies, Inc.
Key Facts
- Brand Name
- CAPLYTA
- Generic Name
- lumateperone
- NDC Code (Product)
72060-121- Manufacturer
- Intra-Cellular Therapies, Inc
- Strength
- 21 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA209500
- Drug Class
- Atypical Antipsychotic [EPC]
- Marketing Start
- 08/09/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is CAPLYTA used for?
CAPLYTA contains lumateperone. It is a capsule taken oral. Consult your doctor for specific uses.
Is CAPLYTA a controlled substance?
CAPLYTA is not classified as a controlled substance by the DEA.
What is the generic name for CAPLYTA?
The generic name for CAPLYTA is lumateperone. There are no other listed brand versions of lumateperone.
What is the NDC code for CAPLYTA 21 mg/1?
The NDC (National Drug Code) for CAPLYTA 21 mg/1 is 72060-121, listed by Intra-Cellular Therapies, Inc.
Other CAPLYTA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)